| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | NPC1 SLC12A6 CACNA1C CACNA1D ABCC3 ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B IPO8 SLC35D2 SLC5A9 ATP13A5 OCA2 OTOP3 ANO10 ATP9A PKDREJ SLC7A11 SLC12A5 ITPR1 SLC5A11 ABCG4 PKD2L2 P2RX3 SLC15A1 KCNC3 SCN7A SLC28A2 OTOP1 SERINC3 CACNA1I PACC1 GJB7 SLC29A1 KCNH5 SLC35B1 | 4.12e-13 | 1289 | 154 | 38 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D ABCC3 ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B IPO8 SLC35D2 SLC5A9 ATP13A5 OCA2 OTOP3 ANO10 PKDREJ SLC7A11 SLC12A5 ITPR1 SLC5A11 ABCG4 PKD2L2 P2RX3 SLC15A1 KCNC3 SCN7A SLC28A2 OTOP1 SERINC3 CACNA1I PACC1 GJB7 SLC29A1 KCNH5 SLC35B1 | 7.23e-13 | 1180 | 154 | 36 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B SLC5A9 ATP13A5 OCA2 OTOP3 ANO10 PKDREJ SLC12A5 ITPR1 SLC5A11 PKD2L2 P2RX3 SLC15A1 KCNC3 SCN7A SLC28A2 OTOP1 CACNA1I PACC1 SLC29A1 KCNH5 | 1.36e-11 | 793 | 154 | 28 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D ABCC3 ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B SLC5A9 OCA2 OTOP3 ANO10 PKDREJ SLC12A5 ITPR1 SLC5A11 PKD2L2 SLC15A1 KCNC3 SCN7A SLC28A2 OTOP1 CACNA1I PACC1 SLC29A1 KCNH5 | 2.73e-11 | 758 | 154 | 27 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 ATP13A5 OTOP3 ANO10 PKDREJ SLC12A5 ITPR1 SLC5A11 PKD2L2 P2RX3 SLC15A1 KCNC3 SCN7A SLC28A2 OTOP1 CACNA1I SLC29A1 KCNH5 | 5.05e-11 | 664 | 154 | 25 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR8K1 HCAR2 GPR21 GPR31 NTRK1 FPR2 PECAM1 LMBR1 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR14K1 OR52B4 HCAR3 PTPRC P2RX3 ADGRG2 BRS3 PLXNC1 OR4A16 SCN7A HRH4 OPN5 OR10J4 TAS2R31 TAS2R43 TAS2R50 ADGRL3 | 1.59e-10 | 1353 | 154 | 35 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8K1 HCAR2 GPR21 GPR31 FPR2 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR14K1 OR52B4 HCAR3 ADGRG2 BRS3 OR4A16 HRH4 OPN5 OR10J4 TAS2R31 TAS2R43 TAS2R50 ADGRL3 | 8.32e-10 | 884 | 154 | 27 | GO:0004930 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 OTOP3 PKDREJ SLC12A5 ITPR1 SLC5A11 PKD2L2 SLC15A1 KCNC3 SCN7A SLC28A2 OTOP1 CACNA1I SLC29A1 KCNH5 | 3.02e-09 | 627 | 154 | 22 | GO:0022890 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 PKDREJ SLC12A5 ITPR1 SLC5A11 PKD2L2 KCNC3 SCN7A SLC28A2 CACNA1I SLC29A1 KCNH5 | 3.42e-09 | 465 | 154 | 19 | GO:0046873 |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 CACNA1C CACNA1D SCN11A CLCA4 OCA2 OTOP3 ANO10 PKDREJ SLC12A5 ITPR1 PKD2L2 P2RX3 KCNC3 SCN7A OTOP1 CACNA1I PACC1 GJB7 KCNH5 | 4.24e-09 | 525 | 154 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D SCN11A CLCA4 OCA2 OTOP3 ANO10 PKDREJ SLC12A5 ITPR1 PKD2L2 P2RX3 KCNC3 SCN7A OTOP1 CACNA1I PACC1 GJB7 KCNH5 | 4.37e-09 | 526 | 154 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C CACNA1D SCN11A CLCA4 OCA2 OTOP3 ANO10 PKDREJ ITPR1 PKD2L2 P2RX3 KCNC3 SCN7A OTOP1 CACNA1I PACC1 KCNH5 | 1.00e-07 | 459 | 154 | 17 | GO:0005216 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 ABCC3 ATP13A4 SLC4A8 ATP7B IPO8 SLC35D2 SLC5A9 ATP13A5 SLC7A11 SLC12A5 SLC5A11 ABCG4 SLC15A1 SLC28A2 SLC29A1 SLC35B1 | 1.73e-07 | 477 | 154 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1C CACNA1D SCN11A OTOP3 ANO10 PKDREJ ITPR1 PKD2L2 P2RX3 KCNC3 SCN7A OTOP1 CACNA1I KCNH5 | 4.51e-07 | 343 | 154 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A6 SLC4A8 SLC5A9 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 | 3.97e-06 | 119 | 154 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC4A8 SLC35D2 SLC5A9 SLC7A11 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 SLC35B1 | 1.94e-05 | 296 | 154 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A6 SLC4A8 SLC5A9 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 | 2.18e-05 | 150 | 154 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A6 ATP13A4 SLC4A8 ATP7B SLC5A9 ATP13A5 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 | 2.26e-05 | 301 | 154 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.28e-05 | 125 | 154 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.55e-05 | 171 | 154 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.55e-05 | 171 | 154 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1C CACNA1D CLCA4 ANO10 ITPR1 P2RX3 KCNC3 SCN7A CACNA1I PACC1 KCNH5 | 5.83e-05 | 334 | 154 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 5.91e-05 | 2 | 154 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 9.15e-05 | 59 | 154 | 5 | GO:1901505 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.54e-04 | 14 | 154 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.73e-04 | 151 | 154 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.73e-04 | 151 | 154 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | UDP-glucose transmembrane transporter activity | 1.76e-04 | 3 | 154 | 2 | GO:0005460 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.01e-04 | 109 | 154 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 3.37e-04 | 18 | 154 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | nucleoside:sodium symporter activity | 3.51e-04 | 4 | 154 | 2 | GO:0005415 | |
| GeneOntologyMolecularFunction | purine nucleoside transmembrane transporter activity | 3.51e-04 | 4 | 154 | 2 | GO:0015211 | |
| GeneOntologyMolecularFunction | mediator complex binding | 3.51e-04 | 4 | 154 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | nucleobase:monoatomic cation symporter activity | 3.51e-04 | 4 | 154 | 2 | GO:0015391 | |
| GeneOntologyMolecularFunction | pyrimidine- and adenosine-specific:sodium symporter activity | 3.51e-04 | 4 | 154 | 2 | GO:0015389 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.09e-04 | 81 | 154 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.98e-04 | 129 | 154 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 5.82e-04 | 5 | 154 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 5.82e-04 | 5 | 154 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.85e-04 | 133 | 154 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 6.22e-04 | 22 | 154 | 3 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 6.22e-04 | 22 | 154 | 3 | GO:0001614 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 7.66e-04 | 140 | 154 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | cyclase activity | 8.08e-04 | 24 | 154 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 8.69e-04 | 6 | 154 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 8.69e-04 | 6 | 154 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 9.13e-04 | 25 | 154 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ATP13A4 ATP7B IPO8 MCM8 ATP13A5 UBA3 ATP9A ABCG4 MYO3A SMC3 CCT8 HFM1 | 9.65e-04 | 614 | 154 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.03e-03 | 26 | 154 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.11e-03 | 59 | 154 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.15e-03 | 27 | 154 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.21e-03 | 7 | 154 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 1.21e-03 | 7 | 154 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 1.21e-03 | 7 | 154 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 1.61e-03 | 8 | 154 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.05e-03 | 9 | 154 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.05e-03 | 9 | 154 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | taste receptor activity | 2.07e-03 | 33 | 154 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.27e-03 | 441 | 154 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 2.55e-03 | 10 | 154 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 2.55e-03 | 10 | 154 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.61e-03 | 178 | 154 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.67e-03 | 36 | 154 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.67e-03 | 36 | 154 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | odorant binding | 3.06e-03 | 127 | 154 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 3.11e-03 | 11 | 154 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 3.11e-03 | 11 | 154 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 3.11e-03 | 11 | 154 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.71e-03 | 12 | 154 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.43e-03 | 86 | 154 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 5.06e-03 | 14 | 154 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.36e-03 | 46 | 154 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8K1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 OR4A16 OR10J4 | 6.34e-03 | 431 | 154 | 9 | GO:0004984 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 6.53e-03 | 152 | 154 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 6.61e-03 | 16 | 154 | 2 | GO:0045125 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 6.76e-03 | 50 | 154 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 7.45e-03 | 17 | 154 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.54e-03 | 52 | 154 | 3 | GO:0005272 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CACNA1D OR8K1 HCAR2 SCN11A GPR21 GPR31 FPR2 OR14J1 F2RL2 ADCY2 S1PR1 OR2L13 BDKRB1 ADCY6 OR14A16 ADCY8 OR6N1 EDNRB ITPR1 LHCGR OR14K1 OR52B4 HCAR3 NSG2 ADGRG2 BRS3 OR4A16 NSG1 HRH4 OPN5 OR10J4 TAS2R31 TAS2R43 TAS2R50 ADGRL3 | 1.85e-10 | 1395 | 155 | 35 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 CACNA1C CACNA1D ABCC3 ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B SLC5A9 ATP13A5 OCA2 OTOP3 ANO10 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 LHCGR PTPRC PKD2L2 P2RX3 SLC15A1 KCNC3 ALG10 SCN7A OTOP1 CACNA1I PACC1 KCNH5 | 2.08e-10 | 1115 | 155 | 31 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B SLC5A9 OCA2 OTOP3 ANO10 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 LHCGR PTPRC PKD2L2 P2RX3 SLC15A1 KCNC3 ALG10 SCN7A OTOP1 CACNA1I PACC1 KCNH5 | 4.91e-10 | 1017 | 155 | 29 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 ATP13A5 OTOP3 ANO10 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 LHCGR PTPRC PKD2L2 P2RX3 SLC15A1 KCNC3 ALG10 SCN7A OTOP1 CACNA1I KCNH5 | 1.91e-09 | 942 | 155 | 27 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 CACNA1C CACNA1D ABCC3 ATP13A4 SCN11A CLCA4 SLC4A8 ATP7B SLC5A9 ATP13A5 OCA2 OTOP3 ANO10 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 SLC5A11 LHCGR PTPRC PKD2L2 P2RX3 SLC15A1 KCNC3 ALG10 SCN7A OTOP1 CACNA1I PACC1 CTNNB1 KCNH5 | 2.06e-09 | 1374 | 155 | 33 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 ATP13A5 OTOP3 ANO10 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 SLC5A11 LHCGR PTPRC PKD2L2 P2RX3 SLC15A1 KCNC3 ALG10 SCN7A OTOP1 CACNA1I CTNNB1 KCNH5 | 9.13e-09 | 1157 | 155 | 29 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 OTOP3 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 LHCGR PTPRC PKD2L2 P2RX3 SLC15A1 KCNC3 ALG10 SCN7A OTOP1 CACNA1I KCNH5 | 2.46e-08 | 922 | 155 | 25 | GO:0098662 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 CACNA1C CACNA1D ATP13A4 SCN11A SLC4A8 ATP7B SLC5A9 PKDREJ BDKRB1 EDNRB SLC12A5 ITPR1 SLC5A11 LHCGR PTPRC PKD2L2 P2RX3 KCNC3 ALG10 SCN7A CACNA1I CTNNB1 KCNH5 | 4.55e-07 | 1000 | 155 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8K1 SCN11A NTRK1 OR14J1 PKDREJ OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 PKD2L2 OR4A16 OTOP1 OPN5 OR10J4 TAS2R31 TAS2R43 CTNNB1 TAS2R50 | 2.14e-06 | 722 | 155 | 19 | GO:0051606 |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 4.12e-06 | 5 | 155 | 3 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 4.12e-06 | 5 | 155 | 3 | GO:0061368 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | CACNA1C FPR2 BDKRB1 ADCY8 EDNRB ITPR1 LHCGR P2RX3 HRH4 CACNA1I | 7.77e-06 | 224 | 155 | 10 | GO:0007204 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1C CACNA1D ATP13A4 SCN11A PKDREJ BDKRB1 EDNRB ITPR1 LHCGR PTPRC PKD2L2 P2RX3 CACNA1I | 8.65e-06 | 392 | 155 | 13 | GO:0070588 |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | NPC1 MAN1A1 SLC35D2 TMEM106A LIPC TMTC3 ALG10 ST8SIA5 CTNNB1 DSEL ALG6 C1GALT1C1L | 1.70e-05 | 357 | 155 | 12 | GO:0009101 |
| GeneOntologyBiologicalProcess | chemical homeostasis | NPC1 SLC12A6 CACNA1C CACNA1D ATP13A4 SLC4A8 GPR21 ATP7B TM9SF4 ATP13A5 OCA2 SLC7A11 BDKRB1 ADCY6 ADCY8 EDNRB SLC12A5 ITPR1 LHCGR ABCG4 LIPC PTPRC SCN7A SLC29A1 | 2.06e-05 | 1249 | 155 | 24 | GO:0048878 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 2.09e-05 | 153 | 155 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.21e-05 | 112 | 155 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1C CACNA1D ATP13A4 SCN11A PKDREJ BDKRB1 EDNRB ITPR1 LHCGR PTPRC PKD2L2 P2RX3 CACNA1I CTNNB1 | 3.13e-05 | 509 | 155 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | CACNA1C CACNA1D TPRG1L FPR2 EDNRB ITPR1 LHCGR PTPRC P2RX3 NR5A1 | 3.42e-05 | 266 | 155 | 10 | GO:0019722 |
| GeneOntologyBiologicalProcess | response to pain | 3.99e-05 | 51 | 155 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | NPC1 MAN1A1 SLC35D2 ADCY2 ADCY6 ADCY8 TMEM106A LIPC TMTC3 ALG10 PIGW ST8SIA5 CTNNB1 DSEL ALG6 HACD1 C1GALT1C1L | 4.04e-05 | 736 | 155 | 17 | GO:1901137 |
| GeneOntologyBiologicalProcess | chloride transport | 5.22e-05 | 128 | 155 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | thermosensory behavior | 5.61e-05 | 2 | 155 | 2 | GO:0040040 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | CACNA1D FPR2 ADCY2 S1PR1 ADCY6 ADCY8 LHCGR ADGRG2 HRH4 ADGRL3 | 6.29e-05 | 286 | 155 | 10 | GO:0007188 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 6.57e-05 | 11 | 155 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 6.99e-05 | 134 | 155 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 7.47e-05 | 183 | 155 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 8.11e-05 | 59 | 155 | 5 | GO:0045761 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC12A6 CACNA1C ATP13A4 SLC4A8 ATP7B TM9SF4 ATP13A5 OCA2 BDKRB1 ADCY8 EDNRB SLC12A5 ITPR1 LHCGR PTPRC SCN7A | 8.45e-05 | 705 | 155 | 16 | GO:0055080 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SLC12A6 CACNA1C CACNA1D ATP13A4 SLC4A8 ATP7B TM9SF4 ATP13A5 OCA2 SLC7A11 BDKRB1 ADCY8 SLC12A5 ITPR1 LHCGR PTPRC SCN7A SLC29A1 | 9.22e-05 | 866 | 155 | 18 | GO:0055082 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 9.36e-05 | 32 | 155 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | NPC1 MAN1A1 SLC35D2 TMEM106A LIPC TMTC3 ALG10 ST8SIA5 CTNNB1 DSEL ALG6 C1GALT1C1L | 1.02e-04 | 430 | 155 | 12 | GO:0009100 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC12A6 CACNA1C ATP13A4 SLC4A8 ATP7B TM9SF4 ATP13A5 OCA2 BDKRB1 ADCY8 EDNRB SLC12A5 ITPR1 LHCGR PTPRC SCN7A | 1.03e-04 | 717 | 155 | 16 | GO:0050801 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8K1 SCN11A NTRK1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 OR4A16 OR10J4 TAS2R31 TAS2R43 TAS2R50 | 1.31e-04 | 582 | 155 | 14 | GO:0050906 |
| GeneOntologyBiologicalProcess | action potential | 1.43e-04 | 201 | 155 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.50e-04 | 36 | 155 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1D OR8K1 SCN11A NTRK1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 MYO3A P2RX3 OR4A16 ALG10 OPN5 OR10J4 TAS2R31 TAS2R43 TAS2R50 NIPBL | 1.60e-04 | 1072 | 155 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.71e-04 | 69 | 155 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1C ATP13A4 SLC4A8 ATP7B TM9SF4 ATP13A5 OCA2 BDKRB1 ADCY8 SLC12A5 ITPR1 LHCGR PTPRC SCN7A | 2.16e-04 | 611 | 155 | 14 | GO:0030003 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 2.24e-04 | 73 | 155 | 5 | GO:0051339 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 2.27e-04 | 40 | 155 | 4 | GO:0045762 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.42e-04 | 217 | 155 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.54e-04 | 75 | 155 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8K1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 P2RX3 OR4A16 OR10J4 TAS2R31 TAS2R43 TAS2R50 | 2.57e-04 | 547 | 155 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1C ATP13A4 SLC4A8 ATP7B TM9SF4 ATP13A5 OCA2 BDKRB1 ADCY8 SLC12A5 ITPR1 LHCGR PTPRC SCN7A | 2.59e-04 | 622 | 155 | 14 | GO:0006873 |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 2.75e-04 | 42 | 155 | 4 | GO:0060402 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8K1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 OR4A16 OR10J4 TAS2R31 TAS2R43 TAS2R50 | 3.10e-04 | 485 | 155 | 12 | GO:0050907 |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 3.13e-04 | 18 | 155 | 3 | GO:1904322 | |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 3.33e-04 | 4 | 155 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | UDP-glucose transmembrane transport | 3.33e-04 | 4 | 155 | 2 | GO:0015786 | |
| GeneOntologyBiologicalProcess | inosine transport | 3.33e-04 | 4 | 155 | 2 | GO:0035340 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 3.40e-04 | 173 | 155 | 7 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 3.64e-04 | 175 | 155 | 7 | GO:0009582 | |
| GeneOntologyBiologicalProcess | response to forskolin | 3.69e-04 | 19 | 155 | 3 | GO:1904321 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 3.69e-04 | 19 | 155 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC12A6 CACNA1C CACNA1D ATP13A4 SLC4A8 ATP7B TM9SF4 ATP13A5 OCA2 SLC7A11 BDKRB1 ADCY8 SLC12A5 ITPR1 LHCGR PTPRC SCN7A SLC29A1 | 4.23e-04 | 981 | 155 | 18 | GO:0019725 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 4.31e-04 | 180 | 155 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 4.62e-04 | 48 | 155 | 4 | GO:0031281 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 4.79e-04 | 86 | 155 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 5.00e-04 | 49 | 155 | 4 | GO:0051349 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.06e-04 | 87 | 155 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 5.11e-04 | 133 | 155 | 6 | GO:0007200 | |
| GeneOntologyBiologicalProcess | adenosine transport | 5.53e-04 | 5 | 155 | 2 | GO:0032238 | |
| GeneOntologyBiologicalProcess | oligopeptide import across plasma membrane | 5.53e-04 | 5 | 155 | 2 | GO:0140205 | |
| GeneOntologyBiologicalProcess | dipeptide import across plasma membrane | 5.53e-04 | 5 | 155 | 2 | GO:0140206 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 5.53e-04 | 5 | 155 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | purine nucleoside transmembrane transport | 5.53e-04 | 5 | 155 | 2 | GO:0015860 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 5.73e-04 | 247 | 155 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 6.14e-04 | 191 | 155 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8K1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 OR52B4 OR4A16 OR10J4 TAS2R31 TAS2R43 TAS2R50 | 6.18e-04 | 524 | 155 | 12 | GO:0009593 |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 6.60e-04 | 23 | 155 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 6.73e-04 | 194 | 155 | 7 | GO:0050714 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 7.81e-04 | 259 | 155 | 8 | GO:0051651 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 7.92e-04 | 96 | 155 | 5 | GO:1901264 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside transport | 8.25e-04 | 6 | 155 | 2 | GO:0015864 | |
| GeneOntologyBiologicalProcess | uridine transmembrane transport | 8.25e-04 | 6 | 155 | 2 | GO:0015862 | |
| GeneOntologyBiologicalProcess | phosphatidylserine metabolic process | 8.48e-04 | 25 | 155 | 3 | GO:0006658 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 8.48e-04 | 25 | 155 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC12A6 CACNA1C ATP13A4 ATP7B ATP13A5 BDKRB1 ADCY8 EDNRB SLC12A5 ITPR1 LHCGR PTPRC SCN7A | 8.59e-04 | 622 | 155 | 13 | GO:0098771 |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 9.31e-04 | 205 | 155 | 7 | GO:0046887 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.06e-03 | 153 | 155 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1C CACNA1D SCN11A SLC4A8 TMEM161B TSPAN9 P2RX3 KCNC3 SCN7A CACNA1I SLC29A1 KCNH5 | 1.08e-03 | 559 | 155 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 1.10e-03 | 154 | 155 | 6 | GO:0051928 | |
| GeneOntologyBiologicalProcess | establishment of mitotic sister chromatid cohesion | 1.15e-03 | 7 | 155 | 2 | GO:0034087 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transport | 1.15e-03 | 7 | 155 | 2 | GO:0015855 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.22e-03 | 62 | 155 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | SLC12A6 CACNA1C SCN11A GPR31 TM9SF4 NTRK1 CAPN2 PKDREJ SLC7A11 BDKRB1 SLC12A5 ITPR1 PTPRC PKD2L2 P2RX3 SCN7A OTOP1 OPN5 CTNNB1 NIPBL SLC29A1 | 1.33e-03 | 1361 | 155 | 21 | GO:0009628 |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.37e-03 | 64 | 155 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.40e-03 | 109 | 155 | 5 | GO:1904427 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 1.46e-03 | 30 | 155 | 3 | GO:0014821 | |
| GeneOntologyBiologicalProcess | nucleoside transmembrane transport | 1.53e-03 | 8 | 155 | 2 | GO:1901642 | |
| GeneOntologyBiologicalProcess | dipeptide transport | 1.53e-03 | 8 | 155 | 2 | GO:0042938 | |
| GeneOntologyBiologicalProcess | adiponectin secretion | 1.53e-03 | 8 | 155 | 2 | GO:0070162 | |
| GeneOntologyBiologicalProcess | regulation of adiponectin secretion | 1.53e-03 | 8 | 155 | 2 | GO:0070163 | |
| GeneOntologyBiologicalProcess | purine nucleobase transmembrane transport | 1.53e-03 | 8 | 155 | 2 | GO:1904823 | |
| GeneOntologyBiologicalProcess | dipeptide transmembrane transport | 1.53e-03 | 8 | 155 | 2 | GO:0035442 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 1.60e-03 | 31 | 155 | 3 | GO:0007635 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | CACNA1C ATP13A4 ATP7B ATP13A5 BDKRB1 ADCY8 ITPR1 LHCGR PTPRC | 1.61e-03 | 359 | 155 | 9 | GO:0006874 |
| GeneOntologyCellularComponent | dendrite | CACNA1C CACNA1D SLC4A8 NTRK1 CAPN2 NUMA1 ARFGEF2 TMEM185A ADCY2 ADCY8 SLC12A5 ITPR1 P2RX3 NSG2 KCNC3 NSG1 HRH4 CTNNB1 | 7.53e-05 | 858 | 156 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1C CACNA1D SLC4A8 NTRK1 CAPN2 NUMA1 ARFGEF2 TMEM185A ADCY2 ADCY8 SLC12A5 ITPR1 P2RX3 NSG2 KCNC3 NSG1 HRH4 CTNNB1 | 7.76e-05 | 860 | 156 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | apical part of cell | SLC12A6 CACNA1D CLCA4 SLC4A8 ATP7B NUMA1 F2RL2 SLC7A11 ADCY8 SLC5A11 SLC15A1 ADGRG2 CTNNB1 SLC29A1 | 1.46e-04 | 592 | 156 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.57e-04 | 17 | 156 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1C CACNA1D SCN11A SLC4A8 NTRK1 CAPN2 NUMA1 ARFGEF2 TMEM185A ADCY2 ADCY8 SLC12A5 ITPR1 P2RX3 NSG2 KCNC3 BRS3 NSG1 HRH4 WDFY3 CTNNB1 | 3.24e-04 | 1228 | 156 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | late endosome membrane | 4.00e-04 | 179 | 156 | 7 | GO:0031902 | |
| GeneOntologyCellularComponent | membrane raft | NPC1 CACNA1C MYADM PECAM1 CAPN2 ADCY2 S1PR1 ADCY8 PTPRC CTNNB1 | 4.01e-04 | 362 | 156 | 10 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | NPC1 CACNA1C MYADM PECAM1 CAPN2 ADCY2 S1PR1 ADCY8 PTPRC CTNNB1 | 4.19e-04 | 364 | 156 | 10 | GO:0098857 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1C CACNA1D SCN11A SLC4A8 ADCY8 SLC12A5 ITPR1 P2RX3 NSG2 KCNC3 NSG1 CTNNB1 ADGRL3 | 4.43e-04 | 583 | 156 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | vesicle membrane | NPC1 ATP13A4 SLC4A8 TPRG1L DSC1 NTRK1 FPR2 PECAM1 CEACAM3 LAIR1 ATP13A5 OCA2 ATP9A ADCY8 ITPR1 ABCG4 PTPRC NSG2 SBF2 NSG1 SLC28A2 | 8.71e-04 | 1325 | 156 | 21 | GO:0012506 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC12A6 CACNA1D CLCA4 SLC4A8 F2RL2 ADCY8 SLC5A11 SLC15A1 ADGRG2 CTNNB1 SLC29A1 | 1.10e-03 | 487 | 156 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.15e-03 | 277 | 156 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | late endosome | 1.24e-03 | 348 | 156 | 9 | GO:0005770 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.29e-03 | 29 | 156 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | cell body | CACNA1C CACNA1D SCN11A SLC4A8 NTRK1 CAPN2 NUMA1 ADCY8 SLC12A5 ITPR1 P2RX3 KCNC3 BRS3 TMEM132E CCT8 WDFY3 | 1.61e-03 | 929 | 156 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | NPC1 ATP13A4 SLC4A8 TPRG1L DSC1 NTRK1 FPR2 PECAM1 CEACAM3 LAIR1 ATP13A5 OCA2 ATP9A ADCY8 ITPR1 ABCG4 PTPRC NSG2 SBF2 NSG1 | 1.77e-03 | 1307 | 156 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | cation channel complex | 1.96e-03 | 235 | 156 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | microvillus | 2.31e-03 | 123 | 156 | 5 | GO:0005902 | |
| MousePheno | abnormal touch/ nociception | NPC1 SLC12A6 CACNA1C ABCC3 SCN11A NTRK1 BDKRB1 ADCY8 EDNRB SLC12A5 P2RX3 TMEM132E XPOT | 7.10e-06 | 376 | 109 | 13 | MP:0001968 |
| MousePheno | abnormal pain threshold | NPC1 SLC12A6 CACNA1C ABCC3 SCN11A NTRK1 BDKRB1 ADCY8 EDNRB SLC12A5 P2RX3 | 7.37e-06 | 267 | 109 | 11 | MP:0001970 |
| MousePheno | abnormal chemical nociception | 2.24e-05 | 44 | 109 | 5 | MP:0002735 | |
| MousePheno | hypoalgesia | 5.43e-05 | 170 | 109 | 8 | MP:0003043 | |
| MousePheno | small ovary | 7.51e-05 | 178 | 109 | 8 | MP:0001127 | |
| Domain | 7tm_1 | OR8K1 HCAR2 GPR21 GPR31 FPR2 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR14K1 OR52B4 HCAR3 BRS3 OR4A16 HRH4 OPN5 | 2.25e-07 | 677 | 156 | 21 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8K1 HCAR2 GPR21 GPR31 FPR2 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR14K1 OR52B4 HCAR3 BRS3 OR4A16 HRH4 OPN5 | 2.73e-07 | 685 | 156 | 21 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8K1 HCAR2 GPR21 GPR31 FPR2 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR14K1 OR52B4 HCAR3 BRS3 OR4A16 HRH4 OPN5 | 3.15e-07 | 691 | 156 | 21 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8K1 HCAR2 GPR21 GPR31 FPR2 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR14K1 OR52B4 HCAR3 BRS3 OR4A16 HRH4 OPN5 | 3.22e-07 | 692 | 156 | 21 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR8K1 HCAR2 GPR21 GPR31 FPR2 OR14J1 F2RL2 S1PR1 OR2L13 BDKRB1 OR14A16 OR6N1 EDNRB LHCGR OR52B4 HCAR3 BRS3 OR4A16 HRH4 OPN5 | 8.16e-07 | 670 | 156 | 20 | IPR017452 |
| Domain | Ion_trans_dom | 5.15e-06 | 114 | 156 | 8 | IPR005821 | |
| Domain | Ion_trans | 5.15e-06 | 114 | 156 | 8 | PF00520 | |
| Domain | Channel_four-helix_dom | 7.87e-06 | 57 | 156 | 6 | IPR027359 | |
| Domain | - | 7.87e-06 | 57 | 156 | 6 | 1.20.120.350 | |
| Domain | Adcy_conserved_dom | 1.12e-05 | 6 | 156 | 3 | IPR009398 | |
| Domain | DUF1053 | 1.12e-05 | 6 | 156 | 3 | PF06327 | |
| Domain | AC_N | 3.10e-05 | 8 | 156 | 3 | IPR032628 | |
| Domain | Adcy | 3.10e-05 | 8 | 156 | 3 | IPR030672 | |
| Domain | AC_N | 3.10e-05 | 8 | 156 | 3 | PF16214 | |
| Domain | VDCCAlpha1 | 6.57e-05 | 10 | 156 | 3 | IPR002077 | |
| Domain | HCAR2/3_rcpt | 6.93e-05 | 2 | 156 | 2 | IPR028017 | |
| Domain | - | 1.40e-04 | 32 | 156 | 4 | 3.40.1110.10 | |
| Domain | - | 1.40e-04 | 32 | 156 | 4 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 2.00e-04 | 35 | 156 | 4 | IPR023299 | |
| Domain | Calcyon | 2.07e-04 | 3 | 156 | 2 | PF06387 | |
| Domain | CAC1F_C | 2.07e-04 | 3 | 156 | 2 | IPR031688 | |
| Domain | Calcyon_neuron-sp | 2.07e-04 | 3 | 156 | 2 | IPR009431 | |
| Domain | CAC1F_C | 2.07e-04 | 3 | 156 | 2 | PF16885 | |
| Domain | Otopetrin | 2.07e-04 | 3 | 156 | 2 | PF03189 | |
| Domain | Otopetrin | 2.07e-04 | 3 | 156 | 2 | IPR004878 | |
| Domain | ATPase_P-typ_P_site | 2.24e-04 | 36 | 156 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 2.24e-04 | 36 | 156 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.24e-04 | 36 | 156 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.50e-04 | 37 | 156 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.50e-04 | 37 | 156 | 4 | PF00122 | |
| Domain | A/G_cyclase_CS | 3.57e-04 | 17 | 156 | 3 | IPR018297 | |
| Domain | TM_Fragile-X-F-assoc | 4.11e-04 | 4 | 156 | 2 | IPR019396 | |
| Domain | Tmemb_185A | 4.11e-04 | 4 | 156 | 2 | PF10269 | |
| Domain | P5-ATPase | 4.11e-04 | 4 | 156 | 2 | PF12409 | |
| Domain | VDCC_L_a1su | 4.11e-04 | 4 | 156 | 2 | IPR005446 | |
| Domain | KCL_cotranspt | 4.11e-04 | 4 | 156 | 2 | IPR000076 | |
| Domain | - | 4.25e-04 | 18 | 156 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.25e-04 | 18 | 156 | 3 | IPR029787 | |
| Domain | Guanylate_cyc | 5.02e-04 | 19 | 156 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.02e-04 | 19 | 156 | 3 | PS50125 | |
| Domain | A/G_cyclase | 5.02e-04 | 19 | 156 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.02e-04 | 19 | 156 | 3 | PS00452 | |
| Domain | CYCc | 5.02e-04 | 19 | 156 | 3 | SM00044 | |
| Domain | TMEM132D_N | 6.82e-04 | 5 | 156 | 2 | PF15705 | |
| Domain | TMEM132D_C | 6.82e-04 | 5 | 156 | 2 | PF15706 | |
| Domain | TMEM132_M | 6.82e-04 | 5 | 156 | 2 | IPR031437 | |
| Domain | TMEM132_C | 6.82e-04 | 5 | 156 | 2 | IPR031436 | |
| Domain | TMEM132_N | 6.82e-04 | 5 | 156 | 2 | IPR031435 | |
| Domain | TDE1/TMS | 6.82e-04 | 5 | 156 | 2 | IPR005016 | |
| Domain | P-type_TPase_V | 6.82e-04 | 5 | 156 | 2 | IPR006544 | |
| Domain | TMEM132 | 6.82e-04 | 5 | 156 | 2 | IPR026307 | |
| Domain | TMEM132 | 6.82e-04 | 5 | 156 | 2 | PF16070 | |
| Domain | PKD_2 | 6.82e-04 | 5 | 156 | 2 | IPR003915 | |
| Domain | DUF4704 | 6.82e-04 | 5 | 156 | 2 | IPR031570 | |
| Domain | Serinc | 6.82e-04 | 5 | 156 | 2 | PF03348 | |
| Domain | DUF4704 | 6.82e-04 | 5 | 156 | 2 | PF15787 | |
| Domain | AA-permease/SLC12A_dom | 7.83e-04 | 22 | 156 | 3 | IPR004841 | |
| Domain | AA_permease | 7.83e-04 | 22 | 156 | 3 | PF00324 | |
| Domain | PH_BEACH | 1.02e-03 | 6 | 156 | 2 | PF14844 | |
| Domain | TAS2R | 1.29e-03 | 26 | 156 | 3 | PF05296 | |
| Domain | T2R | 1.29e-03 | 26 | 156 | 3 | IPR007960 | |
| Domain | Ca_chan_IQ | 1.42e-03 | 7 | 156 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.42e-03 | 7 | 156 | 2 | PF08763 | |
| Domain | SLC12A_fam | 1.42e-03 | 7 | 156 | 2 | IPR004842 | |
| Domain | VDCC_a1su_IQ | 1.42e-03 | 7 | 156 | 2 | IPR014873 | |
| Domain | GPHH | 1.42e-03 | 7 | 156 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.42e-03 | 7 | 156 | 2 | IPR031649 | |
| Domain | SLC12_C | 1.88e-03 | 8 | 156 | 2 | IPR018491 | |
| Domain | PH-BEACH_dom | 1.88e-03 | 8 | 156 | 2 | IPR023362 | |
| Domain | - | 1.88e-03 | 8 | 156 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.88e-03 | 8 | 156 | 2 | PS51783 | |
| Domain | SLC12 | 1.88e-03 | 8 | 156 | 2 | PF03522 | |
| Domain | - | 2.02e-03 | 64 | 156 | 4 | 3.40.50.1000 | |
| Domain | ARM-type_fold | 2.22e-03 | 339 | 156 | 9 | IPR016024 | |
| Domain | MCM | 2.40e-03 | 9 | 156 | 2 | SM00350 | |
| Domain | MCM_dom | 2.40e-03 | 9 | 156 | 2 | IPR001208 | |
| Domain | BEACH | 2.40e-03 | 9 | 156 | 2 | PS50197 | |
| Domain | Beach | 2.40e-03 | 9 | 156 | 2 | PF02138 | |
| Domain | - | 2.40e-03 | 9 | 156 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.40e-03 | 9 | 156 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.40e-03 | 9 | 156 | 2 | IPR000409 | |
| Domain | MCM | 2.40e-03 | 9 | 156 | 2 | IPR031327 | |
| Domain | MCM | 2.40e-03 | 9 | 156 | 2 | PF00493 | |
| Domain | GPS | 2.83e-03 | 34 | 156 | 3 | SM00303 | |
| Domain | Na_channel_asu | 2.99e-03 | 10 | 156 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.99e-03 | 10 | 156 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.99e-03 | 10 | 156 | 2 | PF06512 | |
| Domain | GPS | 3.61e-03 | 37 | 156 | 3 | IPR000203 | |
| Domain | NA_SOLUT_SYMP_1 | 3.63e-03 | 11 | 156 | 2 | PS00456 | |
| Domain | PKD_channel | 3.63e-03 | 11 | 156 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 3.63e-03 | 11 | 156 | 2 | IPR013122 | |
| Domain | HAD-like_dom | 4.33e-03 | 79 | 156 | 4 | IPR023214 | |
| Domain | SSF | 4.33e-03 | 12 | 156 | 2 | PF00474 | |
| Domain | NA_SOLUT_SYMP_2 | 4.33e-03 | 12 | 156 | 2 | PS00457 | |
| Domain | Na/solute_symporter | 4.33e-03 | 12 | 156 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 4.33e-03 | 12 | 156 | 2 | PS50283 | |
| Domain | SSD | 5.09e-03 | 13 | 156 | 2 | IPR000731 | |
| Domain | SSD | 5.09e-03 | 13 | 156 | 2 | PS50156 | |
| Domain | BTB-kelch_protein | 5.52e-03 | 43 | 156 | 3 | IPR017096 | |
| Domain | IBN_N | 6.78e-03 | 15 | 156 | 2 | PF03810 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 SLC12A6 ABCC3 ATP13A4 CLCA4 SLC4A8 ATP7B SLC35D2 SLC5A9 ATP13A5 ANO10 ATP9A SLC7A11 ADCY2 ADCY6 ADCY8 SLC12A5 SLC5A11 ABCG4 LSR LIPC SLC15A1 SLC28A2 SLC29A1 | 4.43e-09 | 736 | 115 | 24 | M27287 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HCAR2 GPR31 FPR2 ADCY2 BDKRB1 ADCY6 ADCY8 ITPR1 HCAR3 HRH4 OPN5 TAS2R31 TAS2R43 TAS2R50 | 2.61e-07 | 314 | 115 | 14 | M600 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 SLC12A6 ABCC3 ATP13A4 CLCA4 SLC4A8 ATP7B SLC35D2 SLC5A9 ATP13A5 ANO10 ATP9A SLC7A11 SLC12A5 SLC5A11 ABCG4 LIPC SLC15A1 SLC28A2 SLC29A1 | 5.59e-07 | 681 | 115 | 20 | MM14985 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HCAR2 GPR31 FPR2 ADCY2 BDKRB1 ADCY6 ADCY8 HCAR3 HRH4 OPN5 TAS2R31 TAS2R43 TAS2R50 | 6.51e-07 | 289 | 115 | 13 | MM15057 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HCAR2 GPR31 FPR2 F2RL2 ADCY2 S1PR1 BDKRB1 ADCY6 ADCY8 EDNRB ITPR1 LHCGR HCAR3 BRS3 HRH4 OPN5 TAS2R31 TAS2R43 TAS2R50 | 1.09e-06 | 646 | 115 | 19 | MM14962 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1C CACNA1D ADCY2 BDKRB1 ADCY8 EDNRB ITPR1 LHCGR P2RX3 CACNA1I | 1.90e-06 | 178 | 115 | 10 | M2890 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HCAR2 GPR31 FPR2 F2RL2 S1PR1 BDKRB1 EDNRB LHCGR HCAR3 BRS3 HRH4 OPN5 TAS2R31 TAS2R43 TAS2R50 | 2.13e-06 | 430 | 115 | 15 | MM15160 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HCAR2 GPR31 FPR2 F2RL2 ADCY2 S1PR1 BDKRB1 ADCY6 ADCY8 EDNRB ITPR1 LHCGR HCAR3 BRS3 HRH4 OPN5 TAS2R31 TAS2R43 TAS2R50 | 3.71e-06 | 702 | 115 | 19 | M746 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HCAR2 GPR31 FPR2 F2RL2 S1PR1 BDKRB1 EDNRB LHCGR HCAR3 BRS3 HRH4 OPN5 TAS2R31 TAS2R43 TAS2R50 | 5.24e-06 | 463 | 115 | 15 | M507 |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 7.09e-06 | 16 | 115 | 4 | M47645 | |
| Pathway | WP_GPCRS_NONODORANT | HCAR2 F2RL2 S1PR1 BDKRB1 EDNRB LHCGR HCAR3 ADGRG2 HRH4 OPN5 ADGRL3 | 1.10e-05 | 266 | 115 | 11 | MM15843 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | HCAR2 GPR31 FPR2 F2RL2 S1PR1 BDKRB1 EDNRB LHCGR HCAR3 BRS3 HRH4 OPN5 | 1.58e-05 | 330 | 115 | 12 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | HCAR2 GPR31 FPR2 F2RL2 S1PR1 BDKRB1 EDNRB LHCGR HCAR3 BRS3 HRH4 OPN5 | 1.73e-05 | 333 | 115 | 12 | MM14963 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC4A8 SLC35D2 SLC5A9 SLC7A11 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 | 2.46e-05 | 238 | 115 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC4A8 SLC35D2 SLC5A9 SLC7A11 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 | 3.62e-05 | 249 | 115 | 10 | M5988 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.22e-05 | 260 | 115 | 10 | M39397 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.09e-05 | 10 | 115 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.09e-05 | 10 | 115 | 3 | MM14668 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 6.34e-05 | 52 | 115 | 5 | M5785 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 8.53e-05 | 29 | 115 | 4 | M47515 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.12e-04 | 31 | 115 | 4 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.27e-04 | 32 | 115 | 4 | M47506 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.40e-04 | 186 | 115 | 8 | MM15994 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.75e-04 | 101 | 115 | 6 | M1979 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.80e-04 | 14 | 115 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.80e-04 | 14 | 115 | 3 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 2.24e-04 | 15 | 115 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 2.24e-04 | 15 | 115 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 2.24e-04 | 15 | 115 | 3 | M47504 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.52e-04 | 108 | 115 | 6 | M17034 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.63e-04 | 70 | 115 | 5 | MM15959 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.74e-04 | 16 | 115 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.74e-04 | 16 | 115 | 3 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.74e-04 | 16 | 115 | 3 | M39849 | |
| Pathway | WP_GPCRS_ODORANT | 2.98e-04 | 157 | 115 | 7 | MM15872 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 3.31e-04 | 17 | 115 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.31e-04 | 17 | 115 | 3 | M47544 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.37e-04 | 41 | 115 | 4 | M512 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.53e-04 | 115 | 115 | 6 | M9387 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.63e-04 | 75 | 115 | 5 | M39696 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.84e-04 | 272 | 115 | 9 | M13380 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.35e-04 | 78 | 115 | 5 | M1921 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 5.45e-04 | 20 | 115 | 3 | M759 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 5.72e-04 | 47 | 115 | 4 | M42524 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | CACNA1D OR8K1 OR14J1 OR2L13 OR14A16 OR6N1 OR14K1 MYO3A OR4A16 OTOP1 OR10J4 TAS2R31 TAS2R43 TAS2R50 | 6.62e-04 | 636 | 115 | 14 | M41834 |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 7.25e-04 | 50 | 115 | 4 | M47951 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.31e-04 | 23 | 115 | 3 | M47666 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 8.38e-04 | 90 | 115 | 5 | M835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 9.45e-04 | 24 | 115 | 3 | M47520 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 9.69e-04 | 6 | 115 | 2 | M47762 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 9.71e-04 | 54 | 115 | 4 | M26911 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.04e-03 | 55 | 115 | 4 | M971 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.07e-03 | 25 | 115 | 3 | M47948 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.19e-03 | 57 | 115 | 4 | MM15643 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.20e-03 | 26 | 115 | 3 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.20e-03 | 26 | 115 | 3 | MM14495 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.29e-03 | 147 | 115 | 6 | MM15854 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.34e-03 | 27 | 115 | 3 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.34e-03 | 27 | 115 | 3 | M47519 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.35e-03 | 7 | 115 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.35e-03 | 7 | 115 | 2 | MM15081 | |
| Pathway | KEGG_MELANOGENESIS | 1.41e-03 | 101 | 115 | 5 | M7761 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.48e-03 | 151 | 115 | 6 | M39329 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.49e-03 | 28 | 115 | 3 | M47647 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 1.49e-03 | 28 | 115 | 3 | M10679 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.53e-03 | 61 | 115 | 4 | MM15071 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.66e-03 | 29 | 115 | 3 | M47627 | |
| Pathway | KEGG_THYROID_CANCER | 1.66e-03 | 29 | 115 | 3 | M523 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.73e-03 | 63 | 115 | 4 | M8 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.89e-03 | 108 | 115 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.97e-03 | 109 | 115 | 5 | MM15074 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 2.01e-03 | 31 | 115 | 3 | MM15691 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.21e-03 | 32 | 115 | 3 | M27455 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 2.29e-03 | 9 | 115 | 2 | M27959 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_LOADING | 2.29e-03 | 9 | 115 | 2 | M47868 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 2.29e-03 | 9 | 115 | 2 | MM15707 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 2.29e-03 | 9 | 115 | 2 | MM1366 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 2.31e-03 | 113 | 115 | 5 | M16817 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.41e-03 | 33 | 115 | 3 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 2.41e-03 | 33 | 115 | 3 | M11575 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.82e-03 | 72 | 115 | 4 | MM14631 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 2.84e-03 | 10 | 115 | 2 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 2.84e-03 | 10 | 115 | 2 | MM14892 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.86e-03 | 35 | 115 | 3 | M47969 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.12e-03 | 74 | 115 | 4 | MM15962 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.19e-03 | 176 | 115 | 6 | MM15718 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.36e-03 | 37 | 115 | 3 | MM15067 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 3.36e-03 | 37 | 115 | 3 | M27847 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 3.36e-03 | 37 | 115 | 3 | M749 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 3.46e-03 | 11 | 115 | 2 | M47614 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.46e-03 | 11 | 115 | 2 | MM15471 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 3.46e-03 | 11 | 115 | 2 | M46429 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.86e-03 | 183 | 115 | 6 | M997 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.90e-03 | 39 | 115 | 3 | MM14496 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.90e-03 | 39 | 115 | 3 | M793 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 4.13e-03 | 12 | 115 | 2 | M27728 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 4.13e-03 | 12 | 115 | 2 | MM16638 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 4.13e-03 | 12 | 115 | 2 | M12851 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 4.50e-03 | 41 | 115 | 3 | MM15075 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 ABCC3 TMED1 MYADM FRAS1 CCPG1 MAN1A1 ARV1 GPX8 TM9SF4 TMEM161B ARFGEF2 ATP9A SLC7A11 MBOAT2 ITPR1 TMTC3 CCT8 PACC1 TMEM164 CTNNB1 DSEL ALG6 SLC29A1 | 1.19e-09 | 1201 | 158 | 24 | 35696571 |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | NPC1 GPR137 TMED1 CLCA4 ARV1 ANO10 ATP9A MBOAT2 ADCY2 BDKRB1 SLC12A5 SERINC3 SLC29A1 SLC35B1 TMEM234 | 7.61e-07 | 697 | 158 | 15 | 28298427 |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 12613887 | ||
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 7.57e-06 | 9 | 158 | 3 | 9417641 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 7.57e-06 | 9 | 158 | 3 | 17229090 | |
| Pubmed | 8.88e-06 | 105 | 158 | 6 | 30280653 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.08e-05 | 10 | 158 | 3 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.08e-05 | 10 | 158 | 3 | 8663304 | |
| Pubmed | 1.08e-05 | 10 | 158 | 3 | 16615126 | ||
| Pubmed | 1.43e-05 | 313 | 158 | 9 | 20800603 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 10089566 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 10808179 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 11299302 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 1.96e-05 | 12 | 158 | 3 | 12379855 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 10807185 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28186140 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30154797 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33461297 | ||
| Pubmed | Wnt-β-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer. | 2.05e-05 | 2 | 158 | 2 | 27709738 | |
| Pubmed | The role of HCA2 (GPR109A) in regulating macrophage function. | 2.05e-05 | 2 | 158 | 2 | 23882124 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36891315 | ||
| Pubmed | Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. | 2.05e-05 | 2 | 158 | 2 | 38007572 | |
| Pubmed | PECAM-1 drives β-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus. | 2.05e-05 | 2 | 158 | 2 | 37580771 | |
| Pubmed | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. | 2.05e-05 | 2 | 158 | 2 | 24691444 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 9205127 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31347703 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21054386 | ||
| Pubmed | Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis. | 2.05e-05 | 2 | 158 | 2 | 30659164 | |
| Pubmed | Different chromosomal localization of two adenylyl cyclase genes expressed in human brain. | 2.05e-05 | 2 | 158 | 2 | 1427768 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19223991 | ||
| Pubmed | Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. | 2.05e-05 | 2 | 158 | 2 | 23967184 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15925480 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26371038 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34653248 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19136666 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33488584 | ||
| Pubmed | Lactate-induced activation of HCA2 improves survival in mice with sepsis. | 2.05e-05 | 2 | 158 | 2 | 30951370 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24086669 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 15537898 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31858105 | ||
| Pubmed | Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy. | 2.05e-05 | 2 | 158 | 2 | 32068460 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30657794 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 2.05e-05 | 2 | 158 | 2 | 26049024 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34092246 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 2.05e-05 | 2 | 158 | 2 | 16706838 | |
| Pubmed | Molecular identification of high and low affinity receptors for nicotinic acid. | 2.05e-05 | 2 | 158 | 2 | 12522134 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23761887 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 2.05e-05 | 2 | 158 | 2 | 25292336 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30271409 | ||
| Pubmed | Macrophages and stromal cells phagocytose apoptotic bone marrow-derived B lineage cells. | 2.05e-05 | 2 | 158 | 2 | 15067047 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17526649 | ||
| Pubmed | Niacin fine-tunes energy homeostasis through canonical GPR109A signaling. | 2.05e-05 | 2 | 158 | 2 | 30596513 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35320002 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12606379 | ||
| Pubmed | GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. | 2.05e-05 | 2 | 158 | 2 | 16322797 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33704440 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 2.05e-05 | 2 | 158 | 2 | 24941892 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18983141 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 31366236 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22826131 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24470632 | ||
| Pubmed | GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice. | 2.05e-05 | 2 | 158 | 2 | 35489706 | |
| Pubmed | Correlation between LHCGR and NR5A1 genes polymorphism and male infertility risk. | 2.05e-05 | 2 | 158 | 2 | 37827240 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24760982 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19561068 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 20014384 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17702579 | ||
| Pubmed | The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. | 2.05e-05 | 2 | 158 | 2 | 24371223 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21774590 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30001160 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17517650 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21352396 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36208084 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26656756 | ||
| Pubmed | Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation. | 2.05e-05 | 2 | 158 | 2 | 37597514 | |
| Pubmed | The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism. | 2.05e-05 | 2 | 158 | 2 | 33924461 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12404111 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33977048 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 2.05e-05 | 2 | 158 | 2 | 17409250 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 11745392 | ||
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 2.05e-05 | 2 | 158 | 2 | 16267232 | |
| Pubmed | Identification of a ubiquitous family of membrane proteins and their expression in mouse brain. | 2.05e-05 | 2 | 158 | 2 | 10637174 | |
| Pubmed | Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. | 2.05e-05 | 2 | 158 | 2 | 25622782 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 29761734 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33420329 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24996399 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12646212 | ||
| Pubmed | PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. | 2.05e-05 | 2 | 158 | 2 | 12563315 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24849370 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30625381 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 7565764 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 11144347 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30085883 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21655214 | ||
| Pubmed | (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. | 2.05e-05 | 2 | 158 | 2 | 15929991 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17015854 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 36991440 | ||
| Interaction | SLC22A9 interactions | ARV1 GPX8 TM9SF4 TMEM115 LMBR1 ATP9A BIRC6 SERINC1 ALG10 PIGW ALG6 SLC29A1 | 9.07e-11 | 120 | 149 | 12 | int:SLC22A9 |
| Interaction | LPAR1 interactions | GPR137 GPR21 ARV1 TM9SF4 TMEM161B LMBR1 ATP9A ADCY6 SERINC1 ALG10 PIGW TMEM164 ALG6 ADGRL3 | 5.44e-10 | 210 | 149 | 14 | int:LPAR1 |
| Interaction | IPPK interactions | GPR137 ARV1 TMEM161B LMBR1 ATP9A ADCY6 SERINC1 PIGW TMEM164 ADGRL3 | 1.50e-08 | 116 | 149 | 10 | int:IPPK |
| Interaction | YIPF3 interactions | NPC1 TMEM161B FPR2 LMBR1 ATP9A S1PR1 ADCY6 ALG10 PIGW ADGRL3 | 1.27e-06 | 186 | 149 | 10 | int:YIPF3 |
| Interaction | TTYH1 interactions | SLC12A6 ATP7B TMEM161B TMEM115 LMBR1 ANO10 ADCY6 TMTC3 ALG10 PIGW TMEM164 SLC29A1 | 2.45e-06 | 300 | 149 | 12 | int:TTYH1 |
| Interaction | CLEC2D interactions | 1.63e-05 | 197 | 149 | 9 | int:CLEC2D | |
| Interaction | CCR6 interactions | 5.18e-05 | 89 | 149 | 6 | int:CCR6 | |
| GeneFamily | Olfactory receptors, family 14 | 8.61e-06 | 7 | 115 | 3 | 163 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.91e-05 | 10 | 115 | 3 | 53 | |
| GeneFamily | Solute carriers | SLC12A6 SLC4A8 SLC35D2 SLC5A9 SLC7A11 SLC12A5 SLC5A11 SLC15A1 SLC28A2 SLC29A1 SLC35B1 | 4.39e-05 | 395 | 115 | 11 | 752 |
| GeneFamily | Hydroxy-carboxylic acid receptors | 1.20e-04 | 3 | 115 | 2 | 200 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 3.96e-04 | 5 | 115 | 2 | 1213 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.86e-04 | 26 | 115 | 3 | 253 | |
| GeneFamily | MCM family | 1.40e-03 | 9 | 115 | 2 | 1085 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.40e-03 | 9 | 115 | 2 | 1230 | |
| GeneFamily | Taste 2 receptors | 1.94e-03 | 39 | 115 | 3 | 1162 | |
| GeneFamily | Kelch like|BTB domain containing | 2.40e-03 | 42 | 115 | 3 | 617 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CACNA1C CACNA1D ABCC3 FRAS1 NAALADL2 S1PR1 TMEM132C SBF2 SCN7A | 3.56e-08 | 197 | 157 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 1.59e-07 | 169 | 157 | 8 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.22e-07 | 192 | 157 | 8 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.39e-07 | 193 | 157 | 8 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.33e-07 | 198 | 157 | 8 | 5a85c286f79cde5811d2595a3397c6fb7685adee | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 2.87e-06 | 174 | 157 | 7 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 2.98e-06 | 175 | 157 | 7 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.59e-06 | 180 | 157 | 7 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.72e-06 | 181 | 157 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 4.45e-06 | 186 | 157 | 7 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-06 | 190 | 157 | 7 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.30e-06 | 191 | 157 | 7 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.49e-06 | 192 | 157 | 7 | ff435141329e3e29fa9b08a4d5b2f55074e7f9ab | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 5.72e-06 | 126 | 157 | 6 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.87e-06 | 194 | 157 | 7 | e13923860a64ba9cf32df53c9f0cf4e7c321881d | |
| ToppCell | droplet-Lung-1m-Endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.87e-06 | 194 | 157 | 7 | b1a25e3b36e7b7e558ef95ec22a3bdcbceae821f | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-06 | 194 | 157 | 7 | 68efc6df31479839a3bd5fe9fbc98ddceecc3b10 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-06 | 194 | 157 | 7 | 03985e4ab10f140f758e70dc7bfaa059b4e3bb18 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.87e-06 | 194 | 157 | 7 | 86508dd9b9d345b6624d185048cc92b81dd11c2a | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 6.07e-06 | 195 | 157 | 7 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.28e-06 | 196 | 157 | 7 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | facs-Heart|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 197 | 157 | 7 | 6a9571c0a3238b39214afdece93d7541bc8a0a70 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.71e-06 | 198 | 157 | 7 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.71e-06 | 198 | 157 | 7 | 1282db321e27499d310339d6383974614e295a20 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.71e-06 | 198 | 157 | 7 | 8d9858dcb21f20d0c040b22a2cae543eaebd54bc | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-06 | 198 | 157 | 7 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | severe-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.16e-06 | 200 | 157 | 7 | f04d5951bac4dee47c22aaf7973312ca797f322e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-05 | 139 | 157 | 6 | fa0eedebf53317928022c3bed391ce99a2114f98 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 156 | 157 | 6 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 156 | 157 | 6 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 160 | 157 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 160 | 157 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-05 | 162 | 157 | 6 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-05 | 162 | 157 | 6 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 97 | 157 | 5 | a1279377bf0ee5662db8b9303f5f1fd418dee6df | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 97 | 157 | 5 | 12cbd03b33e76e5e471bbee2a9c11f27e8b21123 | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 2.75e-05 | 166 | 157 | 6 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 166 | 157 | 6 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 168 | 157 | 6 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-05 | 169 | 157 | 6 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-05 | 169 | 157 | 6 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.14e-05 | 170 | 157 | 6 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 3.14e-05 | 170 | 157 | 6 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-05 | 171 | 157 | 6 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-05 | 171 | 157 | 6 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-05 | 172 | 157 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 3.35e-05 | 172 | 157 | 6 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-05 | 179 | 157 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.19e-05 | 179 | 157 | 6 | d16dc58b5b22762a5a3c875563ced18022d08908 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.55e-05 | 56 | 157 | 4 | f535a4d6d487f186152124704e6922fc0e575847 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-05 | 183 | 157 | 6 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 4.74e-05 | 183 | 157 | 6 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.03e-05 | 185 | 157 | 6 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.03e-05 | 185 | 157 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-05 | 186 | 157 | 6 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-05 | 186 | 157 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.19e-05 | 186 | 157 | 6 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.19e-05 | 186 | 157 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-05 | 186 | 157 | 6 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.19e-05 | 186 | 157 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 187 | 157 | 6 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 187 | 157 | 6 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.50e-05 | 188 | 157 | 6 | db0652f000d459493321b53239326706eace598c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 188 | 157 | 6 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.50e-05 | 188 | 157 | 6 | b4d695c373195d389e0a579e9589e87433286b24 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 188 | 157 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.67e-05 | 189 | 157 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.67e-05 | 189 | 157 | 6 | 235c24eeab5139f5821fccd5c879d8787682f4ef | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 5.83e-05 | 190 | 157 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | PND01-Endothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.01e-05 | 191 | 157 | 6 | 96b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.01e-05 | 191 | 157 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.18e-05 | 192 | 157 | 6 | 53d438e35c14e7656585942b788459e6d843c555 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Neutrophil|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.18e-05 | 192 | 157 | 6 | 3db74359c30172a51177e00eac1f48f483e15578 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.18e-05 | 192 | 157 | 6 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 193 | 157 | 6 | b6b065b0c2ad31d1488dfa970450b29a8ac1f3aa | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.36e-05 | 193 | 157 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 6.36e-05 | 193 | 157 | 6 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 193 | 157 | 6 | 4513e6cb3f86d9cc56e7892fbe11a861335bd179 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.36e-05 | 193 | 157 | 6 | b044fca95f519ff2ceb378afe40a95911931a29e | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 193 | 157 | 6 | 30254658a2023ea9808cdd786530b966a1446418 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.36e-05 | 193 | 157 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.36e-05 | 193 | 157 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | severe-Myeloid-CD16_Monocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.55e-05 | 194 | 157 | 6 | 1b33248b8a7cb914783bcf9e6a80481b4db7e0e8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-05 | 194 | 157 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | f6c9cc362ccdbc7e790f7c8d1c56cab3557c5306 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.74e-05 | 195 | 157 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | moderate-Myeloid|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.93e-05 | 196 | 157 | 6 | 76a4c615ea7594e99c1a938d6900a1b262cc09f5 | |
| ToppCell | NS-moderate-d_16-33-Myeloid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.93e-05 | 196 | 157 | 6 | dc8483625f1188771eb98bd94757b25163b2fc2f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.13e-05 | 197 | 157 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.13e-05 | 197 | 157 | 6 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 197 | 157 | 6 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | facs-Heart-RV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 197 | 157 | 6 | a2d9d3098e5103290b434919dbbc40d7e79fcae0 | |
| Drug | verapamil | CACNA1C CACNA1D ABCC3 HCAR2 BIRC6 ADCY2 ADCY6 ADCY8 ITPR1 ABCG4 HCAR3 MYO3A KCNC3 SCN7A CACNA1I KCNH5 | 2.78e-07 | 490 | 156 | 16 | CID000002520 |
| Drug | myo-inositol | CACNA1C CACNA1D FPR2 ADCY2 S1PR1 BDKRB1 ADCY6 ADCY8 EDNRB ITPR1 SLC5A11 LHCGR PTPRC P2RX3 BRS3 ALG10 PIGW HRH4 CACNA1I DSEL | 7.52e-07 | 811 | 156 | 20 | CID000000892 |
| Drug | sodium | SLC12A6 CACNA1C CACNA1D ABCC3 HCAR2 SLC4A8 ATP7B SLC7A11 ADCY2 ADCY6 ADCY8 SLC12A5 SLC5A11 HCAR3 P2RX3 SLC15A1 SCN7A SLC28A2 SLC29A1 PHTF1 KCNH5 | 2.02e-06 | 944 | 156 | 21 | CID000000923 |
| Drug | TMB-8 | 3.62e-06 | 176 | 156 | 9 | CID000005494 | |
| Drug | otenzepad | 3.82e-06 | 61 | 156 | 6 | CID000107867 | |
| Drug | lanthanum | 4.55e-06 | 136 | 156 | 8 | CID000023926 | |
| Drug | lercanidipine | 4.62e-06 | 63 | 156 | 6 | CID000065866 | |
| Drug | NSC7524 | 4.76e-06 | 182 | 156 | 9 | CID000005657 | |
| Drug | AC1L1TJF | 6.08e-06 | 66 | 156 | 6 | CID000003377 | |
| Drug | gallopamil | 6.64e-06 | 67 | 156 | 6 | CID000001234 | |
| Drug | nicardipine | 7.31e-06 | 145 | 156 | 8 | CID000004473 | |
| Drug | potassium | SLC12A6 CACNA1C CACNA1D HCAR2 CLCA4 SLC7A11 ADCY2 ADCY6 ADCY8 SLC12A5 ITPR1 SLC5A11 HCAR3 P2RX3 KCNC3 ALG10 SCN7A HRH4 CACNA1I KCNH5 | 1.93e-05 | 1008 | 156 | 20 | CID000000813 |
| Drug | 2',3'-dideoxyadenosine | 2.14e-05 | 82 | 156 | 6 | CID000020039 | |
| Drug | Cinnarizine | 2.57e-05 | 9 | 156 | 3 | DB00568 | |
| Drug | Substance P | HCAR2 NTRK1 ADCY2 BDKRB1 ADCY6 ADCY8 EDNRB HCAR3 P2RX3 BRS3 HRH4 | 2.58e-05 | 343 | 156 | 11 | CID000036511 |
| Drug | brimonidine | 2.81e-05 | 86 | 156 | 6 | CID000002435 | |
| Drug | AC1L63MU | HCAR2 FPR2 ADCY2 BDKRB1 ADCY6 ADCY8 EDNRB LHCGR HCAR3 HRH4 CTNNB1 | 2.86e-05 | 347 | 156 | 11 | CID000285703 |
| Drug | saccharin | 3.42e-05 | 54 | 156 | 5 | CID000005143 | |
| Drug | 2',5'-dd3'-FSBA | 3.66e-05 | 10 | 156 | 3 | CID003081206 | |
| Drug | NC-5Z | 3.66e-05 | 10 | 156 | 3 | CID003035914 | |
| Drug | tetrahydrofurfuryl alcohol | 3.82e-05 | 28 | 156 | 4 | CID000007360 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1C CACNA1D NTRK1 FPR2 ADCY2 BDKRB1 ADCY6 ADCY8 EDNRB ITPR1 BRS3 HRH4 CACNA1I XPOT | 3.82e-05 | 568 | 156 | 14 | CID000000806 |
| Drug | tolazoline | 4.41e-05 | 29 | 156 | 4 | CID000005504 | |
| Drug | propranolol | CACNA1C CACNA1D HCAR2 BIRC6 ADCY2 BDKRB1 ADCY6 ADCY8 ITPR1 HCAR3 HRH4 CACNA1I | 4.69e-05 | 434 | 156 | 12 | CID000004946 |
| Drug | AC1L40QM | 5.00e-05 | 11 | 156 | 3 | CID000099213 | |
| Drug | B-Mlvp | 5.00e-05 | 11 | 156 | 3 | CID000195648 | |
| Drug | Mibefradil | 5.00e-05 | 11 | 156 | 3 | DB01388 | |
| Drug | AC1NY9KD | 5.00e-05 | 11 | 156 | 3 | CID005771741 | |
| Drug | NSC759576 | 5.33e-05 | 191 | 156 | 8 | CID000003075 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | SLC12A6 CACNA1C CACNA1D NUMA1 ADCY6 ADCY8 SLC12A5 ITPR1 KCNC3 CACNA1I | 5.46e-05 | 308 | 156 | 10 | CID000001915 |
| Drug | nitrendipine | 5.88e-05 | 98 | 156 | 6 | CID000004507 | |
| Drug | glibenclamide | CACNA1C CACNA1D ABCC3 CLCA4 ATP7B TMEM176B ADCY6 ADCY8 EDNRB ABCG4 LIPC | 6.82e-05 | 382 | 156 | 11 | CID000003488 |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 6508_UP | |
| Drug | CNS 1145 | 7.43e-05 | 33 | 156 | 4 | CID000190902 | |
| Drug | IHC-64 | 7.43e-05 | 33 | 156 | 4 | CID000162753 | |
| Drug | FCE 23884 | 8.58e-05 | 13 | 156 | 3 | CID000065898 | |
| Drug | procaine | 9.10e-05 | 153 | 156 | 7 | CID000004914 | |
| Drug | pyraclofos | 9.12e-05 | 106 | 156 | 6 | CID000093460 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 9.87e-05 | 155 | 156 | 7 | 6817_DN | |
| Drug | oxotremorine | 1.01e-04 | 108 | 156 | 6 | CID000004630 | |
| Drug | AC1NSKJI | 1.04e-04 | 68 | 156 | 5 | CID005311391 | |
| Drug | AC1L1KS5 | CACNA1C CACNA1D FPR2 BDKRB1 ADCY6 ADCY8 EDNRB ITPR1 BRS3 CACNA1I | 1.07e-04 | 334 | 156 | 10 | CID000005631 |
| Drug | AC1L1XPX | 1.31e-04 | 38 | 156 | 4 | CID000011606 | |
| Drug | BMY 42393 | 1.35e-04 | 15 | 156 | 3 | CID000131961 | |
| Drug | caffeine | CACNA1C CACNA1D HCAR2 ADCY2 ADCY6 ADCY8 PPP4R3A ITPR1 HCAR3 LSR PKD2L2 P2RX3 CACNA1I | 1.37e-04 | 562 | 156 | 13 | CID000002519 |
| Drug | CAS 298-57-7 | 1.46e-04 | 73 | 156 | 5 | CID000002761 | |
| Disease | epilepsy (implicated_via_orthology) | 1.70e-06 | 163 | 147 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | 46,XY Sex Reversal 3 | 7.37e-05 | 3 | 147 | 2 | C3489793 | |
| Disease | hepatitis (implicated_via_orthology) | 7.37e-05 | 3 | 147 | 2 | DOID:2237 (implicated_via_orthology) | |
| Disease | 46, XY Disorders of Sex Development | 7.37e-05 | 3 | 147 | 2 | C2751824 | |
| Disease | Male Pseudohermaphroditism | 7.37e-05 | 3 | 147 | 2 | C0238395 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.47e-04 | 4 | 147 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 1.47e-04 | 4 | 147 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 1.47e-04 | 4 | 147 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | Ovarian Failure, Premature | 1.51e-04 | 21 | 147 | 3 | C0085215 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 2.44e-04 | 5 | 147 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 2.44e-04 | 5 | 147 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 2.44e-04 | 5 | 147 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 2.44e-04 | 5 | 147 | 2 | C4551851 | |
| Disease | De Lange syndrome | 3.65e-04 | 6 | 147 | 2 | cv:C0270972 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 3.65e-04 | 6 | 147 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | Manic Disorder | 4.43e-04 | 71 | 147 | 4 | C0024713 | |
| Disease | Congenital Pain Insensitivity | 5.09e-04 | 7 | 147 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 5.09e-04 | 7 | 147 | 2 | C0020075 | |
| Disease | Periventricular Nodular Heterotopia | 5.09e-04 | 7 | 147 | 2 | C1868720 | |
| Disease | Manic | 6.34e-04 | 78 | 147 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 6.65e-04 | 79 | 147 | 4 | C0005587 | |
| Disease | Bipolar Disorder | 6.74e-04 | 477 | 147 | 9 | C0005586 | |
| Disease | neuroblastoma (is_marker_for) | 6.77e-04 | 8 | 147 | 2 | DOID:769 (is_marker_for) | |
| Disease | Cornelia De Lange Syndrome | 6.77e-04 | 8 | 147 | 2 | C0270972 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 7.67e-04 | 36 | 147 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Allodynia | 8.38e-04 | 84 | 147 | 4 | C0458247 | |
| Disease | Mechanical Allodynia | 8.38e-04 | 84 | 147 | 4 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 8.38e-04 | 84 | 147 | 4 | C0751212 | |
| Disease | Hyperalgesia, Primary | 8.38e-04 | 84 | 147 | 4 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 8.38e-04 | 84 | 147 | 4 | C0751214 | |
| Disease | Tactile Allodynia | 8.38e-04 | 84 | 147 | 4 | C0751213 | |
| Disease | Hyperalgesia | 8.38e-04 | 84 | 147 | 4 | C0020429 | |
| Disease | Inherited neuropathies | 1.05e-03 | 40 | 147 | 3 | C0598589 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement | 1.08e-03 | 10 | 147 | 2 | EFO_0800608 | |
| Disease | neuroblastoma (is_implicated_in) | 1.08e-03 | 10 | 147 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 1.22e-03 | 93 | 147 | 4 | C1535926 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.29e-03 | 43 | 147 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | 1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0800269 | |
| Disease | Methionine sulfoxide measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0021650 | |
| Disease | niacinamide measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0010511 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.67e-03 | 276 | 147 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | vascular endothelial growth factor measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0004762 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.19e-03 | 17 | 147 | 2 | OBA_2045173 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.22e-03 | 303 | 147 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | diet measurement, body mass index | 4.42e-03 | 20 | 147 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | obesity (implicated_via_orthology) | 4.54e-03 | 215 | 147 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | macrophage inflammatory protein 1b measurement | 4.85e-03 | 136 | 147 | 4 | EFO_0008219 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFKSNLVCAFIVLLF | 711 | P40145 | |
| LVCAFIVLLFITAIQ | 716 | P40145 | |
| LTQFCILFKRTFLSI | 371 | Q9H172 | |
| VIKANLFISIFLVVA | 116 | P46663 | |
| LILVVALTQFCVAFF | 1116 | Q4VNC0 | |
| ERCISVVQKLVLFLL | 2326 | Q9NR09 | |
| LVKLACIVVASFVLC | 231 | Q9Y672 | |
| ALLVFCFICFIQLLI | 676 | O43306 | |
| LIIQLGVCLFILFAD | 1076 | Q4VNC1 | |
| NLIFFILCTFVQLLG | 696 | P35670 | |
| QALVTLVVVLFALCF | 221 | O00270 | |
| EVLLTFKIFLVIICL | 16 | Q8IZP9 | |
| KNLCISLFVAELLFL | 901 | Q9HAR2 | |
| FASLLIKCVVQLELI | 1546 | Q9Y6D5 | |
| VAKTVFCLVLVFALC | 321 | P24530 | |
| LKVLQQFAACFLETL | 701 | Q13111 | |
| QQALSILLVKFFIIL | 86 | Q6ZS30 | |
| ILLVKFFIILCRNLS | 91 | Q6ZS30 | |
| ILLAKCLTVLGFVIF | 621 | Q04671 | |
| AQLLALVLELLTFCV | 506 | Q6IN85 | |
| FLISACFKLIQDLLS | 311 | O15438 | |
| ILKVLVFNFLNCFAS | 401 | Q9NW15 | |
| LVLLAGVCVFVLFQI | 346 | Q7RTS5 | |
| ALKEISLFLILCNIT | 526 | Q7RTS5 | |
| VINSCKILATFLLIL | 201 | Q8NGY5 | |
| LTLKDLLFSVCALNV | 171 | O60320 | |
| VKFLAITTDCLQILA | 291 | P35222 | |
| VFACLFLSTLLLVLN | 426 | P04629 | |
| LLKIFCQLFSIHVDA | 126 | Q14667 | |
| LLLLVFLVACFINRK | 3911 | Q86XX4 | |
| ILILNVVAFFIICAC | 531 | P22888 | |
| LLKIVQAFVACIIFG | 166 | A6NDP7 | |
| LILILSVIFIKGNCA | 276 | Q8TD91 | |
| VCFIAVKTLSLIGQL | 76 | Q4G0Z9 | |
| VNFVVCQLFALLAAI | 26 | Q6ZWT7 | |
| NLFKLIVNSLCPVIF | 401 | Q9UJA3 | |
| TLFLLGAFNVCNKII | 2361 | Q14643 | |
| VLSLFCAVLTENKVL | 211 | Q86WG5 | |
| KIFVFILAALILLAQ | 6 | Q8IZN7 | |
| LFNLAVADFLLIICL | 66 | Q8TDS4 | |
| ASLLFLLVNVLCAVL | 146 | Q96N19 | |
| FLCKLIHIVVDINLF | 96 | P25090 | |
| LLFAIVTTLCLVRKF | 436 | Q8WVP7 | |
| SVVFLFCLLLLVLFC | 171 | Q6GTX8 | |
| VVLFLCTFKDITLFK | 121 | Q8NCM2 | |
| LALCISEIIIKILFN | 3556 | Q5CZC0 | |
| LDALICNKSFLVTVI | 1056 | O60486 | |
| SLVQCILQVFFFIAL | 91 | Q9UGF5 | |
| SFLGCVLQLFLVVLL | 91 | Q8NGZ2 | |
| FLLISCGVILNFLKT | 211 | Q8NH70 | |
| IIFLLKRLTFCQNNI | 161 | Q8NGK2 | |
| VIIALLIIAAKCYFL | 611 | P16284 | |
| VSLALAFLACIVFLV | 76 | Q9Y328 | |
| RLVACITTLFLFSKI | 2001 | Q6KC79 | |
| GQVFILNILFFCLLL | 196 | Q6U736 | |
| FLQILPVLDFCKVFL | 131 | Q9P2J3 | |
| LCFSILLVLCIFIQS | 6 | P11150 | |
| LKVLETFVACIIFAF | 176 | Q96S97 | |
| AICFILAAIAILLNL | 211 | Q96S97 | |
| LVLFALAFLTCVVFL | 86 | P42857 | |
| IFTICVSFLQKRLCL | 116 | Q2TBA0 | |
| NCLTKILFGALVVVS | 301 | O75110 | |
| LLAFFILACVLIIFL | 531 | Q7Z2Q7 | |
| LVVCLGLVIRKFLNS | 356 | Q6ZVX9 | |
| CLKNVFSVLLIFIYL | 61 | Q9H813 | |
| KASLLILVIFTICFA | 301 | O00254 | |
| FAVLLNSLILAKCFR | 906 | A2PYH4 | |
| LAVFIDFLLQITCFV | 766 | O15118 | |
| KVLRNIAAFLFLCNI | 541 | Q7RTM1 | |
| AIFILVCIESVFKKL | 91 | Q08462 | |
| VCIESVFKKLLRLFS | 96 | Q08462 | |
| FFCIFIVQILVLPKT | 611 | Q08462 | |
| FSSGLNKCVILALVI | 211 | Q9ULG6 | |
| VQLIEVVKFCCSFLL | 111 | Q96M94 | |
| LIQKLAACFFTLSII | 311 | Q96PB1 | |
| FEIIILLTIFANCVA | 126 | Q13936 | |
| VCLKLIKVFVLTSNF | 206 | Q9H2C2 | |
| VLAFIFLNCITIALE | 1176 | Q9P0X4 | |
| KFFQTFALLEIVHCL | 116 | B0YJ81 | |
| ILLLLVVFLYKCFQG | 21 | A8MZ97 | |
| LLELSKSIRVFCIIF | 61 | P0DN25 | |
| ILSLFCFKLFVKISL | 21 | Q8WWX0 | |
| LVAALVCFLLLAKTG | 166 | P40198 | |
| LFLGAIFQLICVLAI | 26 | Q9NQG1 | |
| KFVLLLVFSAFITLC | 41 | P33908 | |
| IFCKQLLFSLLVLTL | 11 | Q08554 | |
| LKILGLLAVVVAFFC | 516 | Q99518 | |
| KTIFILFLVITSCLC | 176 | Q6PEY0 | |
| IVLNFIELSFLVLKC | 191 | Q6PEY0 | |
| VLCTVTLFLLQLKFL | 26 | Q8TED1 | |
| NFCLLEVLIIVFLTV | 26 | Q99679 | |
| NFVRCLVRLETLFKI | 661 | P17655 | |
| NKFASLFLACVIVSI | 341 | Q9UHW9 | |
| LFAALLLVVCVIFAI | 651 | P46059 | |
| VFILICCFIILENIF | 51 | P21453 | |
| CCFIILENIFVLLTI | 56 | P21453 | |
| KFNIAVGLILCISLV | 771 | Q8IZU8 | |
| FILLAIFANCVALAI | 131 | Q01668 | |
| LSFISLELCVLQKLT | 461 | Q9H9A6 | |
| LFVVVVCLAAFLIFL | 261 | Q86X29 | |
| TVLCDIILLNFLKGA | 336 | P56373 | |
| AVLQLQDCSIFIKII | 26 | Q14980 | |
| NKFALVFLGCVILSI | 276 | Q9H2X9 | |
| LFLFLGLKQVCATRQ | 866 | O15397 | |
| KEFITLLISLCVLVL | 196 | P0C629 | |
| ALILINVVLDFCCFI | 196 | Q8NHC5 | |
| QTGIFLLCLIILIFF | 21 | Q8N349 | |
| LAKSLAILLGVFAVC | 301 | Q9H3N8 | |
| KALQTVIFFLLLCAV | 226 | P59538 | |
| KALQTVISFLLLCAI | 226 | P59537 | |
| KALQTLISFLLLCAI | 226 | P59544 | |
| HTKLFVFLAVLICLV | 91 | Q96A25 | |
| KNVVFILQFLLSCFL | 236 | Q76EJ3 | |
| QEFVCLKFIILFSLD | 366 | Q13285 | |
| SLVALALIFAIQKCD | 1121 | Q9UQE7 | |
| IFALVCCFAILVALI | 71 | Q8N7P1 | |
| LAILVFLINCATFAL | 936 | Q8N3T6 | |
| AILVFLINCIVFVLR | 901 | Q6IEE7 | |
| CLLVLSFAIKVLFSL | 141 | Q8NDZ6 | |
| CSVNILQFIFIALRL | 146 | Q8NFB2 | |
| CSVNILQFIFIALKL | 146 | Q9H7F4 | |
| LNFALKCIFTVLIVL | 2001 | Q9NTG1 | |
| KCIFTVLIVLFLRKH | 2006 | Q9NTG1 | |
| LFNLAVADFLLIICL | 66 | P49019 | |
| IFICAFALVTLLQQI | 21 | O15466 | |
| ITALFLLAIFCKRVT | 471 | Q2M3M2 | |
| LVKTLLDVNLIFCVS | 651 | Q8WWX8 | |
| VSLFLTIKLFKLSFC | 161 | Q8NGG5 | |
| KVHLFTLIQLTCLVL | 951 | Q2Y0W8 | |
| VFIQCVINAVFAKIL | 56 | P78383 | |
| KLFTAIRALFLAVCV | 201 | Q3YBM2 | |
| ACILNFQRALALFVI | 96 | O43868 | |
| TCLVIFVLVHSFLKK | 111 | O43868 | |
| LKNISVLAFSVCFIF | 286 | Q99808 | |
| FCFILIQLVLLIDFA | 161 | Q9NRX5 | |
| LIKVACFLLLAAISL | 336 | Q7Z7B1 | |
| QLTKAVVLACLLDFL | 141 | Q96A09 | |
| KLLQEIHSLLCFLVF | 211 | P32247 | |
| ICLFTVIVPQKLLEF | 401 | Q5BKT4 | |
| VFSLLKISQRIVCLV | 296 | Q14CN2 | |
| ESLQFLLDTCKVLVI | 61 | Q8TBC4 | |
| QIFLTFCKLTAILII | 191 | Q9UPY5 | |
| LCISLVTFVLQLFLF | 16 | Q8N966 | |
| LQKVFVQILVKLCSF | 186 | Q8IZQ1 | |
| FLHIFLLLQKISVSL | 16 | Q96N35 | |
| FLFLVFIILVVSCSQ | 536 | Q92544 | |
| IIVLSIINFFERLCL | 526 | Q9UMS5 | |
| FAIQCSRILKLTLFV | 76 | Q92734 | |
| SKNLLLVALCLTFGV | 91 | Q5U3C3 | |
| VSTAKCQLLFALKVL | 166 | Q9BRJ7 | |
| FVILALQLLLACSLE | 1271 | A6NE52 | |
| LCQLESFKALLIQAV | 206 | Q5T0D9 | |
| VVVKALCAAVLFLYL | 21 | Q12893 | |
| LLLLLLCFVAVSFNT | 321 | Q9NZM6 | |
| ENKFFISINLILCVV | 236 | Q13530 | |
| NQFLTLFCVKDLEIL | 101 | Q495X7 | |
| AQKTCFIILSKLVEL | 841 | O43592 | |
| FTDLFLIICIILNVC | 506 | Q01118 | |
| KKLVNVIILTFFCLS | 251 | Q9UI33 | |
| LVAVLQVCTLKRFFQ | 206 | Q13445 | |
| AVVSVIFLKVCKLFL | 101 | Q6ZXV5 | |
| KALLVLLSLGCFFSV | 1126 | Q9BZH6 | |
| EVFLAKLIAQACVSI | 176 | P50990 | |
| SKALIAFLAFLIIVT | 576 | P08575 | |
| ICNSLAIIFTLIVGK | 86 | Q8WY98 | |
| IKENKCLLLSFFIVL | 76 | O75954 | |
| ESKCALVTFFFILLL | 81 | O60635 | |
| FLKSSLNIIDCVAIL | 376 | Q14003 | |
| LKILCTATILFIFGI | 126 | Q58DX5 | |
| IDKLILIQACVRAFL | 1056 | Q8NEV4 |